BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32787079)

  • 21. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET.
    Prante O; Tietze R; Hocke C; Löber S; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2008 Mar; 51(6):1800-10. PubMed ID: 18307287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB
    Heimann D; Börgel F; de Vries H; Patberg M; Jan-Smith E; Frehland B; Schepmann D; Heitman LH; Wünsch B
    Eur J Med Chem; 2018 Feb; 146():409-422. PubMed ID: 29407967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging.
    Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2010 Mar; 18(6):2099-2106. PubMed ID: 20189815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
    Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B
    J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
    Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
    Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography.
    Ritawidya R; Wenzel B; Teodoro R; Toussaint M; Kranz M; Deuther-Conrad W; Dukic-Stefanovic S; Ludwig FA; Scheunemann M; Brust P
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31731831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging.
    Caillé F; Cacheux F; Peyronneau MA; Jego B; Jaumain E; Pottier G; Ullmer C; Grether U; Winkeler A; Dollé F; Damont A; Kuhnast B
    Mol Pharm; 2017 Nov; 14(11):4064-4078. PubMed ID: 28968497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.
    Ni R; Müller Herde A; Haider A; Keller C; Louloudis G; Vaas M; Schibli R; Ametamey SM; Klohs J; Mu L
    Mol Imaging Biol; 2022 Oct; 24(5):700-709. PubMed ID: 34642898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Characterization of Fluorine-18-Labeled
    Wang J; Qu X; Shoup TM; Yuan G; Afshar S; Pan C; Zhu A; Choi JK; Kang HJ; Poutiainen P; El Fakhri G; Zhang Z; Brownell AL
    J Med Chem; 2020 Mar; 63(6):3381-3389. PubMed ID: 32081008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-Based Design, Optimization, and Development of [
    Gündel D; Deuther-Conrad W; Ueberham L; Kaur S; Otikova E; Teodoro R; Toussaint M; Lai TH; Clauß O; Scheunemann M; Bormans G; Bachmann M; Kopka K; Brust P; Moldovan RP
    J Med Chem; 2022 Jul; 65(13):9034-9049. PubMed ID: 35771668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging.
    Modemann DJ; Mahardhika AB; Yamoune S; Kreyenschmidt AK; Maaß F; Kremers S; Breunig C; Sahlmann CO; Bucerius J; Stalke D; Wiltfang J; Bouter Y; Müller CE; Bouter C; Meller B
    Eur J Med Chem; 2022 Mar; 232():114138. PubMed ID: 35193075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facile and high-yield synthesis of N-(4-diethylamino)benzyl-4-[¹¹C]methoxy-N-(p-tolyl)benzenesulfonamide as a new potential PET selective CB2 radioligand.
    Gao M; Xu J; Wang M; Zheng QH
    Appl Radiat Isot; 2014 Aug; 90():181-6. PubMed ID: 24768996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
    Gao Y; Horti AG; Kuwabara H; Ravert HT; Hilton J; Holt DP; Kumar A; Alexander M; Endres CJ; Wong DF; Dannals RF
    J Med Chem; 2007 Aug; 50(16):3814-24. PubMed ID: 17629263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Autotaxin
    Deng X; Salgado-Polo F; Shao T; Xiao Z; Van R; Chen J; Rong J; Haider A; Shao Y; Josephson L; Perrakis A; Liang SH
    J Med Chem; 2021 Oct; 64(20):15053-15068. PubMed ID: 34662125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
    Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
    Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
    J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain.
    Slavik R; Bieri D; Cermak S; Müller A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    Chimia (Aarau); 2014; 68(4):208-10. PubMed ID: 24983598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.